Strategic Wealth Advisors Group, LLC Iovance Biotherapeutics, Inc. Transaction History
Strategic Wealth Advisors Group, LLC
- $2.33 Billion
- Q3 2022
A detailed history of Strategic Wealth Advisors Group, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Strategic Wealth Advisors Group, LLC holds 31,300 shares of IOVA stock, worth $244,453. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,300Holding current value
$244,453% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
314Shares Held
241MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$213 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$208 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$187 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$103 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.23B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...